Data / Research funding / Pennsylvania / Geisinger Clinic
Geisinger Clinic: 23 NIH awards ($49.3M), fiscal years 2021 to 2026
Geisinger Clinic in Danville, PA is funded under 23 NIH awards ($49.3M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- JQH2GEMCAVN5
- State
- Pennsylvania
Awards
23 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $7,542,201 | August 14, 2014 | July 31, 2026 | PANIKKAR, RAJIV | reporter.nih.gov |
| Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders | NIH | National Institute of Mental Health | 2021 to 2023 | $5,538,172 | June 10, 2019 | March 31, 2026 | MARTIN, CHRISTA LESE | reporter.nih.gov |
| Real-time genetic diagnosis at the point of care | NIH | National Human Genome Research Institute | 2021 to 2025 | $4,619,886 | August 10, 2021 | August 31, 2026 | WILLIAMS, MARC S. | reporter.nih.gov |
| Gene Dosage Imbalance in Neurodevelopmental Disorders | NIH | National Institute of Mental Health | 2022 to 2025 | $3,189,018 | March 15, 2005 | December 31, 2026 | MARTIN, CHRISTA LESE | reporter.nih.gov |
| Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,991,274 | August 15, 2019 | July 31, 2028 | MORALES REYES, ANA | reporter.nih.gov |
| Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,954,136 | July 1, 2022 | June 30, 2027 | OETJENS, MATTHEW | reporter.nih.gov |
| Characterizing the spectrum of genomic and phenotypic variation in cerebral palsy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,685,980 | July 1, 2022 | June 30, 2027 | MYERS, SCOTT | reporter.nih.gov |
| Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,525,727 | March 20, 2020 | February 28, 2026 | WILLIAMS, MARC S. | reporter.nih.gov |
| Feasibility and Assessment of a Cascade Traceback Screening program - FACTS | NIH | National Cancer Institute | 2021 to 2023 | $2,213,234 | June 1, 2020 | May 31, 2025 | BUCHANAN, ADAM H | reporter.nih.gov |
| Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,175,818 | February 1, 2022 | January 31, 2027 | GIDDING, SAMUEL S | reporter.nih.gov |
| A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,873,937 | January 19, 2019 | December 31, 2024 | CARRUTH, ERIC DAVID | reporter.nih.gov |
| 7/7-PsycheMERGE: Advancing Precision Psychiatry | NIH | National Institute of Mental Health | 2024 to 2025 | $1,613,367 | September 16, 2024 | May 31, 2029 | CHABRIS, CHRISTOPHER F. | reporter.nih.gov |
| Making Genomic Medicine Routine in a Rural Healthcare System | NIH | National Human Genome Research Institute | 2024 to 2025 | $1,336,194 | September 23, 2024 | July 31, 2029 | BUCHANAN, ADAM H | reporter.nih.gov |
| Blood Trauma, Vascular Remodeling, and Vasoregulation with Total Body Continuous Versus Pulsatile Artificial Circulation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,318,895 | August 9, 2024 | May 31, 2029 | BARTOLI, CARLO R | reporter.nih.gov |
| Reporting Adult-Onset Genomic Results to Pediatric Biobank Participants and Parents | NIH | National Human Genome Research Institute | 2021 to 2022 | $1,218,822 | September 19, 2018 | June 30, 2024 | BUCHANAN, ADAM H | reporter.nih.gov |
| Evaluation of a peer recovery support program adapted to target retention in clinic-based medication for opioid use disorder treatment | NIH | National Institute on Drug Abuse | 2023 | $943,458 | September 30, 2023 | August 31, 2025 | POULSEN, MELISSA | reporter.nih.gov |
| Advancing Perinatal Genomic Discoveries through Patient Engagement and Data Sharing | NIH | National Human Genome Research Institute | 2025 | $754,561 | August 14, 2025 | June 30, 2029 | RIGGS, ERIN ROONEY | reporter.nih.gov |
| Clinical and Genetic Study of Prescription Opioid Addiction | NIH | National Institute on Drug Abuse | 2021 | $737,349 | September 1, 2017 | May 31, 2024 | TROIANI, VANESSA | reporter.nih.gov |
| Evaluation of a peer recovery support program adapted to target retention in clinic-based medication for opioid use disorder treatment | NIH | National Institute on Drug Abuse | 2025 | $680,562 | September 30, 2023 | July 31, 2029 | POULSEN, MELISSA | reporter.nih.gov |
| Assessing the relationship between extreme heat and cardiovascular and pulmonary outcomes to identify strategies for health system intervention | NIH | National Heart, Lung, and Blood Institute | 2025 | $679,906 | September 25, 2025 | June 30, 2029 | POULSEN, MELISSA | reporter.nih.gov |
| Understanding the role of community determinants in opioid use disorder and program implementation factors influencing patient adherence to opioid agonist therapy | NIH | National Institute on Drug Abuse | 2021 to 2024 | $648,128 | July 1, 2020 | December 31, 2025 | POULSEN, MELISSA | reporter.nih.gov |
| Implementing Universal Lynch Syndrome Screening across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizational Contexts | NIH | National Cancer Institute | 2021 | $637,674 | August 1, 2017 | July 31, 2023 | RAHM, ALANNA K | reporter.nih.gov |
| Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH | NIH | National Heart, Lung, and Blood Institute | 2022 | $422,934 | February 1, 2022 | January 31, 2023 | JONES, LANEY K | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 13 | $10,493,627 | 0 | $0 |
| 2024 | 12 | $9,031,409 | 0 | $0 |
| 2023 | 12 | $10,272,726 | 0 | $0 |
| 2022 | 13 | $10,615,132 | 0 | $0 |
| 2021 | 11 | $8,888,339 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Clinical Research
- Prevention
- Genetics
- Health Services
- Human Genome
- Brain Disorders
- Dissemination and Implementation Research
- Social Determinants of Health
- Cardiovascular
- Pediatric
- Behavioral and Social Science
- Clinical Trials and Supportive Activities
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.